[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![PersimmonTI Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::4496252499.png) Persimmon Tree Investments [@PersimmonTI](/creator/twitter/PersimmonTI) on x 9587 followers
Created: 2025-05-20 00:25:04 UTC

$PFE — PD-1 x VEGF

$SMMT $TIL $GLYC $CMPX $BNTX

Pfizer is officially in the PD-1 x VEGF business, in-licensing a Chinese molecule of its own…

after inking a CT collab with $SMMT Ivonescimab for combo with ADCs. 

Note that the deal with 3SBio includes the option for $PFE to commercialize in China, as well as — pretty unusual. 

Also, pretty hefty upfront of $XXX billion, with up to $XXX billion in milestones…

Though the upfront number is in-line with Bourla’s guidance of smaller, bolt-on acquisitions in oncology… 

$xbi

![](https://pbs.twimg.com/media/GrWh1znX0AAHAvK.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1924622365406724131/c:line.svg)

**Related Topics**
[china](/topic/china)
[$1530hk](/topic/$1530hk)
[combo](/topic/combo)
[collab](/topic/collab)
[$bntx](/topic/$bntx)
[$cmpx](/topic/$cmpx)
[$glyc](/topic/$glyc)
[$til](/topic/$til)

[Post Link](https://x.com/PersimmonTI/status/1924622365406724131)